The Advanced Microfluidics Initiative (AMI) brings together relevant engineering, analytical and biomedical expertise in Austria and bridges existing “research-to-product gaps” in microfluidics, lab-on-a-chip systems and organ-on-a-chip technology. The Initiative is managed by BNN and its strategic positioning is implemented together with Austrian universities, R&D- and industrial partners.
- Provide members with a platform for the exchange of ideas, technologies and expertise through short communication channels between different microfluidic research teams, interest groups and experts in microfluidics, sensors and biomedicine, as well as large-scale manufacturers of biochips
- Develop microfluidic concepts for life sciences and biotechnology leading to the reduction of animal testing, precision medicine and quality control of biopharmaceutical products
- Build and provide rapid prototyping capabilities, small-series production and small-scale production of biochips, as well as mass production in line with industrial GMP guidelines
- Establish continuous education and training opportunities within the framework of existing studies and onsite training programs, as well as workshops and conferences